Session 2 - Advancements in the tools for adoption of Quality by Design: DoE and PAT

Monday, November 4, 2013: 8:00 AM-11:30 AM
Islands Ballroom F-J (Marriott Marco Island)
Convener:
Jesse McCool - Cytovance Biologics, Oklahoma City, OK
Co-Convener:
Rosa Dominguez - Green Biologics, Didcot, Oxfordshire,



8:00 AM
S8
Emerging Technologies for Improved Fermentation Management
Larry West, CEO, Aspen Brook Consulting, Inc., Park City, UT
8:30 AM
S9
NIR-Spectroscopy for Bioprocess Monitoring & Control
Dan Kopec, Sartorius Stedim North America, Bohemia, NY
9:00 AM
S10
9:30 AM
Break/exhibits open
10:30 AM
S13
Fed-batch Fermentation Optimization Using Three-Level Definitive Screening Design
Khursheed Karim1, Sangram Yadav1 and Maureen Hamilton2, (1)Microbial R&D Services, Lonza Biologics, Inc., Hopkinton, MA, (2)Fermentation R&D, Lonza Biologics, Hopkinton, MA
11:30 AM
S15
Case study: QbD microbial process characterization and validation
Ryan Hamilton, Karthik Veeravalli, John Burr and Michael Laird, Late Stage Cell Culture Department, Genentech, Inc, South San Francisco, CA
See more of: Invited Oral Papers